News
Topics
A Co-authored Paper regarding Immunocompromised type 1 Diabetic Mini-pigs was Published in the Cell Transplantation
Xenogenic Engraftment of Human Induced Pluripotent Stem Cell–Derived Pancreatic Islet Cells in an Immunosuppressive Diabetic Göttingen Mini-pig...
Axcelead DDP has become a certified provider of Single Cell Gene Expression Solution, from 10x Genomics
We’re delighted to announce that Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) has received official certification from...
BIO-Europe: Meet us in Munich, Germany
Axcelead will be exhibiting at upcoming BIO-Europe in Munich, Germany. Visit us at Booth #10 to learn how we...
Discovery On Target 2023: Meet us in Boston
Axcelead will be exhibiting at upcoming Discovery On Target 2023 in Boston. Visit us at Booth #200 to learn how we...
Axcelead Drug Discovery Partners, Inc. has become a certified provider of spatial transcriptomics technology, Visium, from 10x Genomics
We’re delighted to announce that we have received official certification from 10x Genomics as a Certified Service...
